版本:
中国

BRIEF-Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy

April 18 Boston Scientific Corp:

* Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy in patients with diabetes who have previously experienced a heart attack

* Boston Scientific - emblem mri s-icd system has been accepted for parallel review for new indication by fda, centers for medicare & medicaid services

* Boston Scientific Corp- organizations will concurrently review madit s-icd trial data as well as other relevant information to determine fda approval Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐